Shots:
- DeepCyte has launched DeeTox Atlas, the first single-cell metabolomic reference atlas for drug toxicity mechanisms, with enterprise pilots set to begin soon & three of the top 20 pharma companies already in pilot discussions
- Platform is built from 2 independent studies covering ~100 toxicant compounds, 300k cells & ~500 metabolites/cell, generating 3,000+ single-cell measurements per compound across 6 biological replicates, with each compound mapped to a four-level toxicity-mechanism hierarchy linked to established AOPs
- DeepCyte uses the dataset to train a foundation model that predicts toxicity mechanisms for untested compounds, plus it plans to expand the Atlas with additional compounds, toxicity mechanisms, biochemical & clinical data to strengthen predictions
Ref: DeepCyte | Image: DeepCyte
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
